Otherwise, the motility of bladder cancer cells was also restrained when treated with shGSG2 for GSG2 depletion, as presented by wound-healing (P < 0.05 for EJ, P < 0.01 for T24 cells, Figure 2F) and Transwell assays (P < 0.001, Figure 2G). This evidence concerns the gene HASPIN and urinary bladder cancer.